Diclofenac toxicity to hepatocytes: A role for drug metabolism in cell toxicity

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 1, 1999, Pages 65-72

  Bort, Roque ^a,b   Ponsoda, Xavier ^c   Jover, Ramiro ^a,b   Gómez Lechón, M José ^a   Castell, José V ^a,b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOCHROME P450 INHIBITOR; DICLOFENAC; DRUG METABOLITE; FLURBIPROFEN; KETOCONAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PROADIFEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LIVER CELL CULTURE; LIVER TOXICITY; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032912412     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Boobis AR, Brodie MJ, Kahn GC, Fletcher DR, Saunders JH and Davies DS (1980) Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens. Br J Clin Pharmacol 9:11-19.
2. Bort R, Ponsoda X, Carrasco E, Gómez-Lechón MJ and Castell JV (1996) Metabolism of aceclofenac in humans. Drug Metab Dispos 24:834-841.
3. Breen EG, McNicholl J, Cosgrove E, McCabe J and Stevens FM (1986) Fatal hepatitis associated with diclofenac. Gut 27:1390-1393.
4. Cain K and Skilleter DN (1987) Preparation and Use of Mitochondria in Toxicological Research in Biochemical Toxicology: A Practical Approach (Snell K and Mullock B eds) pp 217-254, IRL Press, Oxford.
5. Carmichael J, DeGraff WG, Gazdar AF, Minna JD and Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res 47:936-942.
6. Castell JV, Gómez-Lechón MJ, Ponsoda X and Bort R (1997) In vitro investigation of the molecular mechanisms of hepatotoxicity, in In vitro Methods in Pharmaceutical Research (Castell JV and Gómez-Lechón MJ eds) pp 375-410, Academic Press, London.
7. Castell JV, Montoya A, Larrauri A, López P and Gómez-Lechón MJ (1985) Effects of benorylate and impacina on the metabolism of cultured hepatocytes. Xenobiotica 15:743-749
8. Ciccolunghi SN, Chaudri HA, Schubiger BI and Reddrop R (1978) Report on a long term tolerability study of up to two years with diclofenac sodium (Voltaren). Scand J Rheumatol Suppl 22:116-121.
9. Clement B and Kunze T (1992) The reduction of 6-N-hydroxylaminopurine to adenine by xanthine oxidase Biochem Pharmacol 44:1501-1509.
10. Faigle JW, Böttcher I, Godbillon J, Kriemler HP, Schlumpf E, Schneider W, Schweizer A, Stierlin H and Winkler T (1988) A new metabolite of diclofenac sodium in human plasma. Xenobiotica 18:1191-1197.
11. Gómez-Lechón MJ, López P and Castell JV (1984) Biochemical functionality and recovery of hepatocytes after deep freezing storage. In Vitro 20:826-832.
12. Gómez-Lechón MJ, López P, Donato T, Montoya A, Larrauri A, Giménez P, Trullenque R, Fabra R and Castell JV (1990) Culture of human hepatocytes from small surgical liver biopsies. Biochemical characterization and comparison with in vivo. In Vitro Cell & Dev Biol 26:67-74.
13. Helfgott SM, Sandberg-Cook J, Zakim D and Nestler J (1990) Diclofenac-associated hepatotoxicity. J Am Med Assoc 264:2660-2662.
14. Iveson TJ, Ryley NG, Kelly PMA, Trowell JM, McGee JO'D and Chapman RWG (1990) Diclofenac associated hepatitis. J Hepatol 10:85-89.
15. Jover R, Ponsoda X, Gómez-Lechón MJ and Castell JV (1993) Cocaine hepatotoxicity: two different toxicity mechanisms for phenobarbital-induced and non-induced rat hepatocytes. Biochem Pharmacol 46:1967-1974.
16. Jurima-Romet M, Crawford K and Huang HS (1994) Comparative cytotoxicity of non-steroidal anti-inflammatory drugs in primary cultures of rat hepatocytes. Toxicol In Vitro 8:55-66.
17. Kretz-Rommel A and Boelsterli UA (1993) Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P450-mediated acute cell injury in cultured rat hepatocytes. Toxicol Appl Pharmacol 120:155-161.
18. Leemann T, Transon C and Dayer P (1993) Cytochrome-P450TB (CYP2C): A major monooxygenase catalyzing diclofenac 4′- hydroxylation in human liver. Life Sci 52:29-34.
19. Minta A, Kao JPY and Tsien RY (1989) Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores. J Biol Chem 264:8171-8178.
20. Miyamoto G, Zahid N and Uetrecht JP (1997) Oxidation of diclofenac to reactive intermediates by neutrophils, myeloperoxidase, and hypochlorous acid. Chem Res Toxicol 10: 414-419.
21. Nicotera P, Bellomo G and Orrenius S (1992): Calcium-mediated mechanisms in chemically induced cell death. Annu Rev Pharmacol Toxicol 32:449-470.
22. Nieminen AL, Gores GJ, Dawson TL, Herman B and Lemasters JJ (1990) Toxic injury from mercuric chloride in rat hepatocytes. J Biol Chem 265:2399-2408.
23. Ouellette GS, Slitzky BE, Gates JA, Lagarde S and West AB (1991) Reversible hepatitis associated with diclofenac. J Clin Gastroenterol 13:205-210.
24. Ponsoda X, Bort R, Jover R, Gómez-Lechón MJ and Castell JV (1995) Molecular mechanism of diclofenac hepatotoxicity: association of cell injury with oxidative metabolism and decrease in ATP levels. Toxicol In Vitro 9:439-444.
25. Ponsoda X, Jover R, Castell JV and Gómez-Lechón MJ (1991) Measurement of intracellular LDH activity in 96-well cultures: A rapid and automated assay for cytotoxicity studies. J Tiss Cult Methods 13:21-24.
26. Pumford NR, Myers TG, Davila JC, Highet RJ and Pohl LR (1993) Immunochemical detection of liver protein adducts of the non-steroidal anti-inflammatory drug diclofenac. Chem Res Toxicol 6:147-150.
27. Purcell P, Henry D and Melville G (1991) Diclofenac hepatitis. Gut 32:1381-1385.
28. Relling MV, Aoyama T, Gonzalez FJ and Meyer UA (1990) Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily. J Pharmacol Exp Ther 252:442-447.
29. Riess W, Stierlin H, Degen P, Faigle JW, Gérardin A, Moppert J, Sallmann A, Schmid K, Schweizer A, Sulc M, Theobald W and Wagner J (19781 Pharmacokinetics and metabolism of the anti-inflammatory agent voltaren. Scand J Rheumatol Suppl 22:17-29.
30. Romano A, Pietrantonio F, Di Fonso M, Garcovich A, Chiarelli C, Venuti A and Barone C (1994) Positivity of patch tests in cutaneous reaction to diclofenac. Allergy 49:57-69.
31. Salama A, Gottsche B and Mueller-Eckhardt C (1991) Autoantibodies and drug- or metabolite-dependent antibodies in patients with diclofenac immune haemolysis. Br J Haematol 77:546-549.
32. Sallie R (1990) Diclofenac hepatitis (Letter). J Hepatol 11:281.
33. Schapira D, Bassan L, Nahir AM and Scharf Y (1986) Diclofenac-induced hepatotoxicity. Postgrad Med J 62:63-65.
34. Schmitz G, Lepper H and Estler CJ (1995) Failure of calcium antagonistic agents to prevent hepatotoxicity induced by diclofenac. Pharmacol Toxicol 77: 32-35.
35. Schmitz G, Stauffert I, Sippel H, Lepper H and Estler CJ (1992) Toxicity of diclofenac to isolated hepatocytes. J Hepatol 14:408-409.
36. Scully LJ, Clarke D and Barr RJ (1993) Diclofenac induced hepatitis: three cases with features of autoimmune chronic active hepatitis. Dig Dis Sci 38:744-751.
37. Smith DA and Jones BC (1992) Speculations on the substrate structure-activity relationship (SSAR) of cytochrome P450 enzymes. Biochem Pharmacol 44:2089-2098.
38. Stierling H, Faigle JW, Sallman A, Küng W, Richter WJ, Kriemler HP, Alt KO and Winkler T (1979) Biotransformation of diclofenac sodium (Voltaren) in animals and man. I. Isolation and identification of principal metabolites. Xenobiotica 9:601-610.
39. Tabata K, Yamaoka K, Fukuyama T and Nakagawa T (1996) Local absorption kinetics into the portal system using the portal-venous concentration difference after an oral dose of diclofenac in the awakening rat. Drug Metab Dispos 24:216-220.
40. 5. Biochem Pharmacol 37:368-370.